Concepedia
Statistics
Publications
40
Citations
1.3K
H-Index
20
Active since
1997
Affiliations
Istituto Oncologico Veneto(Current)
Instituto Nacional de Investigaciones Nucleares
University of Padua
Istituti di Ricovero e Cura a Carattere Scientifico
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Laura Meléndez‐Alafort is an author at Istituto Oncologico Veneto specializing in medicine, nuclear medicine, and pharmacology.
Publications per year
1997–2024
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Clemens Decristoforo, Laura Meléndez‐Alafort, Jane Sosabowski et al. · PubMed · 2000 · 162 citations
Medicine, Nuclear Medicine, Pharmacology +17
A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent <i>In vivo</i> Therapeutic Activity
Alessandra Banzato, Sara Bobisse, Maria Rondina et al. · Clinical Cancer Research · 2008 · 90 citations · Full text
Medicine, Oncology, Pharmacology +17
Biokinetics of 99mTc-UBI 29-41 in humans
Laura Meléndez‐Alafort, J. Rodríguez-Cortés, Guillermina Ferro‐Flores et al. · Nuclear Medicine and Biology · 2004 · 84 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +5
In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria
Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy, Martha Pedraza-López et al. · Nuclear Medicine and Biology · 2003 · 82 citations
Life Sciences, Microbiology, Bacteriology +3
177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer
Brenda Gibbens-Bandala, Enrique Morales-Ávila, Guillermina Ferro‐Flores et al. · Materials Science and Engineering C · 2019 · 63 citations · Full text
Pharmacy, Oncology, Pharmacology +16
1–5 of 40